Ask a Patient® Health News: Drugs & Treatments

Huge recall of Glaucoma and Allergy Eye Drops, Recall of Granules' Generic Adderall XR; Acetaminophen Safety; Semaglutide and Serious Eye…

Glaucoma and Allergy Eye Drops Recall by Apotex

19 hrs ago

1

Note to Readers - Newsletter to be sent October 6

Dear Readers,

Oct 4 • 

Katie Rowley

September 2025

Nationwide Recalls for Cyclobenzaprine, Multiple Generics; Warnings for Briviact, Lupron Depot, Riluzole, Tepezza, Tiglutek; Pharma Ad…

Drug Recall: Cyclobenzaprine Hydrochloride

Sep 21 • 

Katie Rowley

3

World’s Essential Medicines: What did and didn't make the list; Medical device sterilization dilemma; Eye drops for nearsightedness, Meds…

Notable Updates to “The Selection and Use of Essential Medicines 2025” and more recent consumer-friendly health news.

Sep 7 • 

Katie Rowley

3

August 2025

FDA To Tighten Regulation of Natural Thyroid Medications

The FDA announced it is looking at taking action against companies selling “unapproved” animal-based thyroid drugs, but not right away.

Aug 25 • 

Katie Rowley

August 2025 Safety Update Part 2: Liver Injury and MS Drugs; Xyzal Warning; Recalls for Metoprolol, Spironolactone, Compounded GLP-1s…

Liver Injury Warnings for MS Drugs

Aug 24

2

August 2025 Drug Safety: Huge Recall of Glaucoma Eye Drops; Duloxetine and Other Generic Recalls; HRT Comments; Opioid and Kratom 7-OH…

Drug Recall: Duloxetine Tablets

Aug 10

5

August 10, 2025: New Drug Approvals for Brain, Lung cancer; Migraine Treatment for Kids; AI therapy banned in IL; Alzheimer's Link to…

Chatbots and AI Banned in Illinois for Mental Health Therapy; New Drug Approval: Modeyso for Brain Cancer; more.

Aug 10

1

July 2025

July 2025 Safety Update: New drug for hand eczema, heart failure; warnings for testosterone meds, Opdivo; FDA halts Elevidys gene therapy…

The latest safety updates from FDA; anemia treatments in older patients; green tea drug interactions.

Jul 27 • 

Katie Rowley

5

Special Update on Alzheimer’s Drugs Leqembi (lecanemab) and Kisunla (donanemab)

New dosing approved for Kisunla for less ARIA side effects; New interactive dashboard of Adverse event reports.

Jul 13 • 

Katie Rowley

June 2025

Expanded Approvals for Dupixent, Keytruda, Mavyret, Nucala, Susvimo; New Meds: Widaplik for High Blood Pressure, Yeztugo for HIV prevention

Readers, these updates for new approvals did not fit in yesterday's newsletter. Susvimo for diabetic retinopathy and more.

Jun 30

2

June 2025 Safety Update Part 2: Warnings for Transderm Scop, Caprelsa, Hyzaar, Xarelto, GLP-1s (Mounjaro and more)

Transderm Scop (scopolamine) patch and Hyperthermia

Jun 29

3